Categories: News

From Investment to Green Card: Golden Gate Global Celebrates another I-829 Approval as an EB-5 Industry Leader

SAN FRANCISCO, Sept. 23, 2025 /PRNewswire/ — Golden Gate Global (GGG), recognized as one of the top EB-5 regional centers, is proud to announce the first approval of an I-829 petition for an investor in its Sacramento Kings Arena & Downtown Commons (DOCO) Phase II Project. The I-829 approval confirms the investor’s permanent residency status in the United States and adds to Golden Gate Global’s long history of immigration success.

- Advertisement -

With a consistent track record of I-526 and I-829 petition approvals for 1,750+ families from 30+ countries, Golden Gate Global has built a reputation as one of the leading EB-5 regional centers nationwide. This latest approval underscores GGG’s role as an industry leader in successfully guiding investors through the full EB-5 process — from project selection to Green card.

- Advertisement -

Equally notable is Golden Gate Global’s exceptional history of $250 million in EB-5 investor repayments with no defaults. Across its portfolio of 19 EB-5 projects, the firm has consistently delivered repayments to investors, setting a benchmark for capital protection and reliability in the EB-5 industry. Together, GGG’s immigration and financial achievements position it firmly among the best EB-5 regional centers for global investors.

- Advertisement -

“Golden Gate Global was founded on the principle of delivering both immigration success and financial security to our investors,” said Steven Kay, Founder & Co-CEO. “This I-829 approval is further proof of our ability to honor that commitment, reinforcing why we are regarded as one of the top EB-5 regional centers in the United States.”

- Advertisement -

Phase II of the Sacramento Kings Arena & Downtown Commons (DOCO) is a landmark development completed in 2019 that has become an iconic destination for world-class entertainment and basketball. Golden 1 Center, at the heart of the DOCO complex, hosts around 130+ events per year, attracting over 1.5 million visitors annually.

- Advertisement -

GGG partners with leading developers and institutional partners to deliver high-quality investment opportunities that create jobs, safeguard capital, and support families in achieving their American Dream.

- Advertisement -

Media Contact:
Jane Baklashov
info@3gfund.com

- Advertisement -

Photo – https://mma.prnewswire.com/media/2777609/Golden_Gate_Global.jpg
Logo – https://mma.prnewswire.com/media/1807027/GOLDEN_GATE_GLOBAL__Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/from-investment-to-green-card-golden-gate-global-celebrates-another-i-829-approval-as-an-eb-5-industry-leader-302561939.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

24 minutes ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

4 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

4 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

4 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

4 hours ago